Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Award ceiling
- Not stated
- Closes
- Not stated
- Last verified
- 2026-10-23
Per-recipient award not stated for city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, others (see text field entitled "additional information on eligibility" for clarification), private institutions of higher education, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, special district governments, state governments.
In one sentence
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed) does not state a per-recipient award amount, open to city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native…
- Program pool (total)
- Not confirmedTotal across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- Not confirmed
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Not stated
- Deadline type
- Not stated
- Opens
- Jun 15, 2026
- Status
- Forecasted
- Eligible entities
- City or township governments · County governments · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · State governments
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- cancer biology approaches · preclinical model systems · investigation of biological effects of radiation emitted by radionuclides used in radiopharmaceutical therapy · mechanistic understanding of radionuclide-emitted radiation effects on normal tissues, tumor cells, and tumor microenvironment · multidisciplinary research integrating cancer biology, radiation biology, radiochemistry, imaging, dosimetry, and preclinical modeling · development of targeting strategies · optimized treatment regimens · innovative combination approaches for radiopharmaceutical therapy
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Who can apply?
+5more
, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governmentsNot confirmed
Source field: applicant size limitOther Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional…
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
What can the money be used for?
8 categorysThe source’s own spending categories, and what is not parsed.
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
Who has received this funding?
2294 awardsAwards on file for this programme, counted rather than modelled.
2294 prior awards on file for this programme, largest first. Every row comes from the funder's own award listing; nothing here is estimated.
| Recipient | State | Amount | Fiscal year |
|---|---|---|---|
| CASE WESTERN RESERVE UNIVERSITY | Not stated | $2,023,294 | 2022 |
| TREVARX BIOMEDICAL, INC | Not stated | $2,022,982 | 2021 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | Not stated | $2,020,293 | 2021 |
| BRIGHAM & WOMENS HOSPITAL INC | Not stated | $2,017,973 | 2015 |
| UNIVERSITY OF TEXAS AT DALLAS | Not stated | $2,016,309 | 2017 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $2,015,561 | 2018 |
| UNIVERSITY OF ARKANSAS | Not stated | $2,011,556 | 2019 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | Not stated | $2,010,669 | 2024 |
| UNIVERSITY OF CALIFORNIA, SAN DIEGO | Not stated | $2,009,866 | 2016 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | Not stated | $2,009,646 | 2024 |
| UNIVERSITY OF TOLEDO | Not stated | $2,006,783 | 2023 |
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | Not stated | $2,004,683 | 2024 |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | Not stated | $2,004,275 | 2019 |
| FISCHER IMAGING INC | Not stated | $2,002,658 | 2022 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $2,001,329 | 2022 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $2,000,741 | 2023 |
| ADECTO PHARMACEUTICALS, INC. | Not stated | $2,000,000 | 2022 |
| INVENIO IMAGING INC | Not stated | $2,000,000 | 2023 |
| MOLECULAR THERANOSTICS LLC | Not stated | $2,000,000 | 2022 |
| ONC.AI, INC. | Not stated | $2,000,000 | 2025 |
| ONC.AI, INC. | Not stated | $2,000,000 | 2024 |
| PHASE GENOMICS INC | Not stated | $2,000,000 | 2023 |
| PHASE GENOMICS INC | Not stated | $2,000,000 | 2023 |
| BINARY GENOMICS, INC | Not stated | $1,999,999 | 2024 |
| DOSEOPTICS LLC | Not stated | $1,999,995 | 2021 |
| MORGAN AND MENDEL GENOMICS, INC | Not stated | $1,999,740 | 2018 |
| GLC BIOTECHNOLOGY INC | Not stated | $1,999,735 | 2023 |
| LYNX DX INC | Not stated | $1,999,642 | 2020 |
| BOSTON CELL STANDARDS INC. | Not stated | $1,999,519 | 2021 |
| AMBERGEN, INC | Not stated | $1,999,488 | 2018 |
| TRIANGLE BIOTECHNOLOGY, INC | Not stated | $1,999,404 | 2018 |
| ENSPECTRA HEALTH, INC. | Not stated | $1,999,298 | 2023 |
| VAJRA INSTRUMENTS INC | Not stated | $1,999,194 | 2015 |
| ORBIT GENOMICS, INC. | Not stated | $1,999,191 | 2024 |
| VERGENT BIOSCIENCE INC | Not stated | $1,998,535 | 2022 |
| VERISKIN, INC | Not stated | $1,998,435 | 2020 |
| SIEGE PHARMACEUTICALS, INC. | Not stated | $1,998,238 | 2020 |
| THE METHODIST HOSPITAL RESEARCH INSTITUTE | Not stated | $1,997,597 | 2020 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | Not stated | $1,996,836 | 2020 |
| MANZANITA PHARMACEUTICALS INC | Not stated | $1,996,496 | 2024 |
| NANOMEDTRIX LLC | Not stated | $1,995,390 | 2018 |
| VERAVANTI INC. | Not stated | $1,995,368 | 2021 |
| CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER | Not stated | $1,995,233 | 2022 |
| PRECYTE INC | Not stated | $1,993,793 | 2016 |
| RARECYTE, INC. | Not stated | $1,993,572 | 2018 |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | Not stated | $1,991,994 | 2017 |
| AIQ GLOBAL INC | Not stated | $1,991,220 | 2020 |
| BIOPTICS TECHNOLOGY LLC | Not stated | $1,990,713 | 2023 |
| OMNISCIENT IMAGING INC | Not stated | $1,989,369 | 2016 |
| VOXIMETRY INC | Not stated | $1,989,181 | 2024 |
| THE JOHNS HOPKINS UNIVERSITY | Not stated | $1,988,300 | 2018 |
| MALCOVA INC | Not stated | $1,988,177 | 2022 |
| WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | Not stated | $1,987,755 | 2021 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $1,986,141 | 2017 |
| AIQ GLOBAL INC | Not stated | $1,985,840 | 2023 |
| OHIO STATE UNIVERSITY, THE | Not stated | $1,985,818 | 2024 |
| SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH | Not stated | $1,985,578 | 2016 |
| EXIMIUS DIAGNOSTICS CORP | Not stated | $1,984,827 | 2023 |
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | Not stated | $1,983,781 | 2021 |
| UNIVERSITY OF ROCHESTER | Not stated | $1,983,616 | 2021 |
| THE LELAND STANFORD JUNIOR UNIVERSITY | Not stated | $1,981,891 | 2017 |
| ACOUSTIC RANGE ESTIMATES, LLC | Not stated | $1,981,853 | 2019 |
| WASHINGTON UNIVERSITY, THE | Not stated | $1,980,734 | 2023 |
| UNIVERSITY OF WISCONSIN SYSTEM | Not stated | $1,978,528 | 2018 |
| UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | Not stated | $1,978,064 | 2022 |
| NUVOX PHARMA, L.L.C. | Not stated | $1,976,897 | 2025 |
| WASHINGTON UNIVERSITY, THE | Not stated | $1,975,853 | 2019 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | Not stated | $1,974,789 | 2018 |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | Not stated | $1,974,102 | 2021 |
| MAYO CLINIC | Not stated | $1,974,006 | 2017 |
| ALARA IMAGING INC | Not stated | $1,973,174 | 2023 |
| MANZANITA PHARMACEUTICALS INC | Not stated | $1,972,907 | 2017 |
| THE GENERAL HOSPITAL CORPORATION | Not stated | $1,969,189 | 2017 |
| IN VIVO ANALYTICS, INC | Not stated | $1,968,807 | 2019 |
| UNIVERSITY OF TEXAS AT DALLAS | Not stated | $1,967,462 | 2019 |
| PET/X LLC | Not stated | $1,967,422 | 2016 |
| UNIVERSITY OF CALIFORNIA, SAN DIEGO | Not stated | $1,967,098 | 2024 |
| LUMICELL INC | Not stated | $1,965,754 | 2016 |
| BAYLOR COLLEGE OF MEDICINE | Not stated | $1,964,839 | 2018 |
| THE JOHNS HOPKINS UNIVERSITY | Not stated | $1,961,859 | 2017 |
| PURDUE UNIVERSITY | Not stated | $1,959,353 | 2020 |
| WASHINGTON UNIVERSITY, THE | Not stated | $1,958,951 | 2024 |
| KESSLER FOUNDATION, INC | Not stated | $1,958,231 | 2014 |
| YALE UNIV | Not stated | $1,957,299 | 2017 |
| INLIGHTA BIOSCIENCES L.L.C. | Not stated | $1,954,220 | 2022 |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | Not stated | $1,953,257 | 2021 |
| UNIVERSITY OF LOUISVILLE | Not stated | $1,948,419 | 2024 |
| ARIZONA STATE UNIVERSITY | Not stated | $1,947,405 | 2024 |
| THE GENERAL HOSPITAL CORPORATION | Not stated | $1,944,636 | 2016 |
| IMAGINE SCIENTIFIC INC | Not stated | $1,942,984 | 2022 |
| BATTELLE MEMORIAL INSTITUTE | Not stated | $1,941,836 | 2022 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | Not stated | $1,936,791 | 2024 |
| CARNEGIE-MELLON UNIVERSITY | Not stated | $1,936,497 | 2018 |
| THE MEDICAL COLLEGE OF WISCONSIN, INC. | Not stated | $1,935,027 | 2017 |
| WASHINGTON UNIVERSITY, THE | Not stated | $1,932,956 | 2019 |
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | Not stated | $1,931,186 | 2022 |
| UNIVERSITY HEALTH NETWORK | Not stated | $1,930,920 | 2022 |
| THE MORGRIDGE INSTITUTE FOR RESEARCH, INC. | Not stated | $1,929,514 | 2016 |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | Not stated | $1,928,691 | 2023 |
| UNIVERSITY OF ILLINOIS | Not stated | $1,928,614 | 2024 |
Recipient names as published by the California Grants Portal.
What comparable notices state
291 recordsStated ceilings on open records in the same industry.
Among open records stored under Health & Human Services, 291 of 887 state an award ceiling. Those that do run:
- 25th percentile$357,500
- Median$600,000
- 75th percentile$1,500,000
A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.
Who has won this programme before?
6330 awardsAwards under the same assistance listing, not under this notice.
6330 federal awards on file under assistance listing 93.394, 93.395, the programme this notice is published under. These are not awards made under this notice — a listing covers every year the programme runs, and awards under an open notice do not exist yet.
- $353,109,533PUBLIC HEALTH INSTITUTECA · FY2014
- $138,088,678OREGON HEALTH & SCIENCE UNIVERSITYOR · FY2014
- $135,357,649THE UNIVERSITY OF CHICAGOIL · FY2014
- $125,672,442NRG ONCOLOGY FOUNDATION INCPA · FY2014
- $115,346,605UNIVERSITY OF SOUTHERN CALIFORNIACA · FY2014
Common questions
4 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- Who is eligible to apply?
- City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments.
- What can the funding be used for?
- cancer biology approaches, preclinical model systems, investigation of biological effects of radiation emitted by radionuclides used in radiopharmaceutical therapy, mechanistic understanding of radionuclide-emitted radiation effects on normal tissues, tumor cells, and tumor microenvironment, multidisciplinary research integrating cancer biology, radiation biology, radiochemistry, imaging, dosimetry, and preclinical modeling, development of targeting strategies, optimized treatment regimens, innovative combination approaches for radiopharmaceutical therapy, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
- Has this programme funded anyone before?
- 2294 prior awards are on file for this programme, made by National Institutes of Health. Recipients, amounts and fiscal years are listed on this page.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inWhat else is open
- Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)Closes Not statedAwards Not stated
- NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – Regional Coordinating Stroke Centers (RCCs)Closes Not statedAwards Not stated
- Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation CenterCloses Not statedAwards Not stated
- Undiagnosed Diseases Network (UDN) Clinical and Data Coordinating CenterCloses Not statedAwards Not stated
- Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed)Closes Not statedAwards Not stated
- Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic ExcellenceCloses Not statedAwards Not stated
A listing names the programme; a notice names one round of it. These are other rounds open now, not other years of this one.
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)Closes Jan 11, 2027Awards up to $700,000
- Forecast to Publish a Notice of Funding Opportunity for SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)Closes Not statedAwards Not stated
- Forecast to Publish a Notice of Funding Opportunity for Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)Closes Not statedAwards Not stated
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)Closes Jan 7, 2027Awards up to $500,000
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)Closes Jan 7, 2027Awards up to $375,000
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)Closes Sep 25, 2029Awards Not stated
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.